Search Results | MSF Science Portal

Journal Article

|

Research

Laureillard D, Marcy O, Madec Y, Chea S, Chan S, et al.

2013-10-23 • AIDS

To analyze cases of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the CAMbodian Early versus Late Introduction of Antiretrovirals (CAMELIA)...

Journal Article

|

Research

Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al.

2011-10-20 • New England Journal of Medicine

Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation...

Journal Article

|

Research

Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, et al.

2014-08-01 • Clinical Infectious Diseases

Shortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency vir...

Journal Article

|

Research

Borand L, Madec Y, Laureillard D, Chou M, Marcy O, et al.

2014-03-07 • PLOS One

OBJECTIVE
To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.

Science Portal

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial

Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial)